仁和药业 (000650.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(仁和药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,237,638,493.595,032,146,123.813,818,691,932.622,681,918,127.261,355,800,163.835,153,215,069.283,845,780,533.162,561,096,047.491,311,390,192.42
 营业利润(元) 264,857,980.25898,634,863.20859,296,002.14562,214,871.62296,051,840.96953,263,271.29751,779,398.05492,297,069.11257,635,696.12
 利润总额(元) 264,397,235.57898,860,221.55858,734,254.05561,138,123.15295,141,919.50953,539,857.97750,564,700.84489,934,398.02257,208,638.83
 净利润(元) 209,797,170.22629,410,311.31652,593,697.28428,261,851.41219,294,118.25711,556,917.04567,081,060.83371,348,992.61194,265,657.36
 归属于母公司股东的净利润(元) 177,296,535.93567,257,498.51540,375,630.58356,548,925.17182,299,215.54574,441,773.76456,457,572.95299,965,510.62155,695,612.25
盈利能力:
 销售毛利率(%) 36.6637.1237.9837.8939.4136.6236.1636.7837.48
 销售净利率(%) 16.9512.5117.0915.9716.1713.8114.7514.5014.81
 净资产收益率(%) 2.949.679.306.323.21----
 总资产报酬率ROA(%) 3.3411.5911.077.513.91----
 投入资本回报率ROIC(%) 2.899.669.006.063.1210.418.375.582.90
营运能力:
 存货周转率(次) 1.987.005.373.501.69----
 应收账款周转率(次) 1.8713.414.473.982.06----
 总资产周转率(次) 0.160.670.500.370.18----
偿债能力:
 资产负债率(%) 11.8910.6114.6613.7713.4715.8511.8112.1313.40
 股东权益比率(%) 79.1580.5075.3076.3577.1875.2277.9477.8977.01
 已获利息倍数(倍) -38.05-35.06-46.46-46.33-41.71-40.34-36.95-33.10-54.51
 流动比率 5.526.104.374.604.563.935.014.994.58
 速动比率 4.995.413.884.084.013.464.394.293.90
发展能力:
 营业收入增长率(%) -8.72-2.35-0.704.723.394.415.096.607.66
 营业利润增长率(%) -10.54-5.7314.3014.2014.91-8.07-4.73-1.5410.79
 税后利润增长率(%) -2.74-1.2518.3818.8617.09-13.62-13.01-9.661.95
 净资产增长率(%) 3.504.396.766.468.828.5812.286.704.21
 总资产增长率(%) 0.92-2.4910.528.608.5910.487.028.727.44

前瞻产业研究院